Science hopes to give women new tools against AIDS

Key points
- New HIV prevention treatments for women may be available as early as 2009, a sign of hope for fighting a world AIDS epidemic with an increasingly feminine face, a top researcher said on Thursday.
- Abdool Karim said initial results from the most promising microbicide human trials could be available by early 2008.
- Microbicides, which women might one day be able to use in gel or cream form to shield themselves from HIV infection, hold some of the best promise for fighting a disease that continues to defy efforts to create a vaccine, said Salim Abdool Karim.
- "We need some kind of prevention technology that is designed for and under the control of women," Abdool Karim, of South Africa's University of KwaZulu-Natal, told an AIDS conference in Durban.
New HIV prevention treatments for women may be available as early as 2009, a sign of hope for fighting a world AIDS epidemic with an increasingly feminine face, a top researcher said on Thursday.
Microbicides, which women might one day be able to use in gel or cream form to shield themselves from HIV infection, hold some of the best promise for fighting a disease that continues to defy efforts to create a vaccine, said Salim Abdool Karim.
"We need some kind of prevention technology that is designed for and under the control of women," Abdool Karim, of South Africa's University of KwaZulu-Natal, told an AIDS conference in Durban.
"Microbicides can be used completely surreptitiously, it does not need a partner's consent," he said.
U.N. estimates show 60 percent of almost 30 million people with HIV infection or AIDS in sub-Saharan Africa are women, a proportion growing particularly in societies where women are less able to refuse sex or negotiate condom use with a male partner.
Even female condoms, introduced in an effort to give women more control over their sexual health, have proven less than completely effective as men may sometimes refuse to agree to having sex with a woman who is wearing one, Abdool Karim said.
Microbicides, which use a variety of means to either kill HIV in the vagina, block it from infecting other cells or prevent it from multiplying, could be an important tool and advanced studies are under way in South Africa and elsewhere to assess their effectiveness, he said.
"South Africa has a huge epidemic among younger women and therefore there is a huge need for microbicides in this setting," he said.
South Africa has the world's biggest single HIV/AIDS caseload with over 5 million of its 45 million people infected.
"INVISIBLE CONDOM"
Abdool Karim said initial results from the most promising microbicide human trials could be available by early 2008. If they prove effective, fast-track regulatory approval, manufacturing and distribution could make the treatments available to women one or two years after that, he said.
AIDS experts estimate microbicides, some of which have names such as "Invisible Condom," could prevent 2.5 million deaths from AIDS over three years.
Abdool Karim, who is overseeing one of five advanced human clinical trials of microbicides, cautioned that it was still too early to say if the treatment would prove effective.
But he said in theory microbicides could protect women from HIV over a period of days, or could be applied after sex as a kind of "morning after pill" to prevent infection.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsStudy finds decline in HIV deaths for most men, women by race/ethnicity, education
Overall death rates due to human immunodeficiency virus (HIV) infection declined over time between 1993 and 2007 for most men and women by race/ethnicity and educational levels, with the largest absolute decreases for…
9 October 2012
NewsHPV Cotesting Safe for HIV+ Women
A cohort of HIV-infected women had no cases of histologically confirmed high-risk cervical neoplasia during follow-up after negative cotesting for human papillomavirus (HPV) infection, investigators reported. Of 245…
11 July 2012
NewsMany poor pregnant women with HIV go untreated for depression
It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan,…


